Brad Hogg supports Ravindra Jadeja after the Nagpur Ointment controversy

Brad Hogg

Brad Hogg, the former Australia spin bowler, spoke out in support of Ravindra Jadeja after the ointment controversy on Day 1 of the first Test of the Border-Gavaskar series at the VCA Stadium in Nagpur. Hogg used Twitter to clarify that Jadeja did not use the ointment on the ball and emphasized that there was no need for further discussion.

Brad Hogg busted Australian media’s fake narrative

Jadeja faced criticism after he appeared to have applied something on his spinning fingers during the first Test of the Border-Gavaskar series at the VCA Stadium in Nagpur. Michael Vaughan and other former cricketers questioned his intentions on social media. Nevertheless, video footage showed that Jadeja was actually applying ointment on his sore fingers. He had informed the match referee about it. Brad Hogg dismissed the controversy, revealing that Jadeja was using a pain relief cream borrowed from his colleague Mohammed Siraj.

Brad Hogg took to the microblogging site to dismiss all the talk and clarify the situation.

He tweeted

If you look closely, there is a cream on Siraj’s hand which stood out clear as day on the TV. Jadeja applied it to his finger, at no stage did he put it on the ball. No need for further discussion.” #AUSvIND

Former Pakistan opener Salman Butt also spoke in support of Ravindra Jadeja after the controversy surrounding the use of ointment. Butt claimed that only people who are illiterate would make such comments and expressed his support for Jadeja.

“The Australian media has accused Ravindra Jadeja of tampering with the ball. But what benefit is a spinner going to get from ball tampering’ Only cricket illiterates can make such comments.”

Jadeja and Ashwin dominated Australia’s batting lineup on the first day of the first Test. Jadeja and Ashwin caused significant damage to the visiting team, with only Marnus providing any resistance. The rest of the Australian batsmen struggled, leading to a total score of 177.

Follow us on Twitter for more!

To Top